Objective. Eicosanoids play a key role in the regulation of inflammation and fibrosis. Recently we showed that levels of 5-lipoxygenase (5-LOX)-derived proinflammatory/profibrotic leukotrienes are elevated in bronchoalveolar lavage (BAL) fluid from patients with scleroderma lung disease (SLD). The present study was undertaken to investigate whether increased levels of leukotrienes are balanced by the antiinflammatory/ antifibrotic cyclooxygenase (COX)-and 15-LOXderived eicosanoids in the lungs of patients with SLD.Methods. Levels of 5-LOX-derived leukotriene B 4 (LTB 4 ), COX-derived prostaglandin E 2 (PGE 2 ), and 15-LOX-derived 15-hydroxyeicosatetraenoic acid (15-HETE) and lipoxin A 4 (LXA 4 ) in BAL fluid from systemic sclerosis (SSc) patients with SLD (n ؍ 32) and without SLD (n ؍ 16) and from healthy individuals (n ؍ 12) were measured by enzyme-linked immunosorbent assay.Results. Levels of LTB 4 (mean ؎ SEM 248 ؎ 29 pg/ml) and PGE 2 (51 ؎ 10 pg/ml) in SSc patients with SLD were significantly higher compared with patients without SLD (LTB 4 119 ؎ 35 pg/ml, PGE 2 17 ؎ 3 pg/ml; P < 0.05 for both) and with healthy controls (85 ؎ 12 pg/ml and 19 ؎ 2 pg/ml, respectively; P < 0.05 for both).